Drug resistant infections are the biggest threat to modern medicine killing more than 700,000 people globally each year. Antibiotic resistance can affect anyone, but it's children, the elderly, people living in poverty and those with weak immune systems most at risk.
It ran from 12:00 PM, 1 December 2020 to 12:00 PM, 8 December 2020
Registered Charity in England and Wales (1157884)
"I hope every day for a new discovery of antibiotics. Medical science needs a lift to find a new cure for the kind of antibiotic resistant infections that have affected my life, but I am determined, will not ruin it."
The UTI I was suffering from wasn’t clearing up. Seven different antibiotics later & still no let up. Finally an answer - ESBL E-coli, an antibiotic resistant infection - but no explanation! There’s a real lack of knowledge about ESBL infections, no support or information for patients.
I am aware that COVID-19 patients can develop serious secondary bacterial infections leading to sepsis. That means they are receiving antibiotics. It has taught us that we have to be prepared for more pandemics to come and unless we develop new antibiotic treatments, people will die.
My partner was diagnosed Acinetobacter baumannii. They think he contracted this due to poor hospital hygiene. All treatment, including antibiotics failed. At 21.45hrs I received a message to say he’d died. We were making plans for the future; plans that we will never now fulfill.
Drug resistant infections are the biggest threat to modern medicine. They already kill more than 700,000 people globally each year. However, as COVID-19 opens the door to secondary bacterial infections, which don’t always respond to antibiotic treatment these figures are now expected to be much higher. The COVID-19 virus weakens the immune system, leaving it susceptible to secondary bacterial infections. In addition the very act of ventilation itself can lead to infections.
We want to UNDERSTAND, SUPPORT and FIND MEDICAL TREATMENTS Understanding those communities and people most affected by antibiotic resistant infections (including the elderly and BAME communities) will help us to target our Patient Support activities, trusted information and medical research programme to best effect
Please upgrade your browser to continue.